JP2009518293A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009518293A5 JP2009518293A5 JP2008543435A JP2008543435A JP2009518293A5 JP 2009518293 A5 JP2009518293 A5 JP 2009518293A5 JP 2008543435 A JP2008543435 A JP 2008543435A JP 2008543435 A JP2008543435 A JP 2008543435A JP 2009518293 A5 JP2009518293 A5 JP 2009518293A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pirfenidone
- administration
- medicament
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 47
- ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical compound C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 claims 28
- 229960003073 pirfenidone Drugs 0.000 claims 28
- 239000003814 drug Substances 0.000 claims 21
- 230000037406 food intake Effects 0.000 claims 13
- 239000002552 dosage form Substances 0.000 claims 11
- 235000012631 food intake Nutrition 0.000 claims 11
- 235000013305 food Nutrition 0.000 claims 7
- 239000002775 capsule Substances 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 206010019233 Headaches Diseases 0.000 claims 2
- 208000032140 Sleepiness Diseases 0.000 claims 2
- 206010041349 Somnolence Diseases 0.000 claims 2
- 230000002411 adverse Effects 0.000 claims 2
- 208000002173 dizziness Diseases 0.000 claims 2
- 231100000869 headache Toxicity 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74197605P | 2005-12-02 | 2005-12-02 | |
| US60/741,976 | 2005-12-02 | ||
| PCT/US2006/045750 WO2007064738A1 (en) | 2005-12-02 | 2006-11-29 | Methods of reducing adverse events associated with pirfenidone therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012187515A Division JP2012229275A (ja) | 2005-12-02 | 2012-08-28 | ピルフェニドン療法に付随する有害事象を低減する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009518293A JP2009518293A (ja) | 2009-05-07 |
| JP2009518293A5 true JP2009518293A5 (https=) | 2009-12-17 |
| JP5175740B2 JP5175740B2 (ja) | 2013-04-03 |
Family
ID=37807840
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008543435A Active JP5175740B2 (ja) | 2005-12-02 | 2006-11-29 | ピルフェニドン療法に付随する有害事象を低減する方法 |
| JP2012187515A Withdrawn JP2012229275A (ja) | 2005-12-02 | 2012-08-28 | ピルフェニドン療法に付随する有害事象を低減する方法 |
| JP2015002231A Pending JP2015061888A (ja) | 2005-12-02 | 2015-01-08 | ピルフェニドン療法に付随する有害事象を低減する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012187515A Withdrawn JP2012229275A (ja) | 2005-12-02 | 2012-08-28 | ピルフェニドン療法に付随する有害事象を低減する方法 |
| JP2015002231A Pending JP2015061888A (ja) | 2005-12-02 | 2015-01-08 | ピルフェニドン療法に付随する有害事象を低減する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070203202A1 (https=) |
| EP (2) | EP1965797B1 (https=) |
| JP (3) | JP5175740B2 (https=) |
| AT (1) | ATE497766T1 (https=) |
| CA (1) | CA2631646C (https=) |
| CY (1) | CY1111355T1 (https=) |
| DE (1) | DE602006020070D1 (https=) |
| DK (1) | DK1965797T3 (https=) |
| ES (2) | ES2385935T3 (https=) |
| PL (1) | PL1965797T3 (https=) |
| PT (1) | PT1965797E (https=) |
| SI (1) | SI1965797T1 (https=) |
| WO (1) | WO2007064738A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070203202A1 (en) | 2005-12-02 | 2007-08-30 | Robinson Cynthia Y | Methods of reducing adverse events associated with pirfenidone therapy |
| SI2124945T1 (sl) * | 2006-12-18 | 2011-08-31 | Intermune Inc | Postopek dajanja terapije s pirfenidonom pacientu |
| US20080287508A1 (en) * | 2007-05-18 | 2008-11-20 | Intermune, Inc. | Altering pharmacokinetics of pirfenidone therapy |
| JP5587184B2 (ja) | 2007-06-20 | 2014-09-10 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 繊維症阻害剤としての置換ｎ−アリールピリジノン |
| US7635707B1 (en) | 2008-11-10 | 2009-12-22 | Intermune, Inc. | Pirfenidone treatment for patients with atypical liver function |
| US7566729B1 (en) | 2008-11-10 | 2009-07-28 | Intermune, Inc. | Modifying pirfenidone treatment for patients with atypical liver function |
| AU2010206543A1 (en) * | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
| US7816383B1 (en) | 2009-12-04 | 2010-10-19 | Intermune, Inc. | Methods of administering pirfenidone therapy |
| US8084475B2 (en) * | 2009-12-04 | 2011-12-27 | Intermune, Inc. | Pirfenidone therapy and inducers of cytochrome P450 |
| US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| JP6021117B2 (ja) | 2011-01-31 | 2016-11-02 | ジェノア ファーマシューティカルズ，インク． | エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用 |
| JP2014507474A (ja) * | 2011-03-08 | 2014-03-27 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換ｎ−アリールピリジノン |
| MX2011007675A (es) * | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| MY168300A (en) * | 2011-09-14 | 2018-10-25 | Shionogi & Co | Pharmaceutical Composition for Inhalation |
| CA2819967C (en) | 2012-08-31 | 2016-03-22 | Intermune, Inc. | Use of pirfenidone concomitantly with ciprofloxacin |
| EP2968292A4 (en) | 2013-03-15 | 2016-11-23 | Intermune Inc | METHOD FOR IMPROVING MICROVASCULAR INTEGRITY |
| NZ760541A (en) | 2014-01-10 | 2022-08-26 | Avalyn Pharma Inc | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| TWI745396B (zh) | 2016-07-12 | 2021-11-11 | 日商鹽野義製藥股份有限公司 | 吸入用醫藥組成物 |
| WO2021107060A1 (ja) * | 2019-11-27 | 2021-06-03 | 塩野義製薬株式会社 | ピルフェニドンの副作用を軽減するための医薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3839346A (en) * | 1972-12-18 | 1974-10-01 | Affiliated Med Res | N-substituted pyridone and general method for preparing pyridones |
| US5310562A (en) * | 1989-11-22 | 1994-05-10 | Margolin Solomon B | Composition and method for reparation and prevention of fibrotic lesions |
| KR100891887B1 (ko) * | 2001-01-29 | 2009-04-03 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1ｈ)-피리돈을 활성 성분으로서 함유하는의약 제제 |
| WO2004110245A2 (en) * | 2003-05-16 | 2004-12-23 | Intermune, Inc. | Combination therapy for cancer treatment |
| US20070203202A1 (en) | 2005-12-02 | 2007-08-30 | Robinson Cynthia Y | Methods of reducing adverse events associated with pirfenidone therapy |
-
2006
- 2006-11-28 US US11/605,199 patent/US20070203202A1/en not_active Abandoned
- 2006-11-29 DK DK06838621.8T patent/DK1965797T3/da active
- 2006-11-29 PL PL06838621T patent/PL1965797T3/pl unknown
- 2006-11-29 EP EP06838621A patent/EP1965797B1/en active Active
- 2006-11-29 ES ES06838621T patent/ES2385935T3/es active Active
- 2006-11-29 PT PT06838621T patent/PT1965797E/pt unknown
- 2006-11-29 JP JP2008543435A patent/JP5175740B2/ja active Active
- 2006-11-29 EP EP10075728.5A patent/EP2316453B1/en not_active Revoked
- 2006-11-29 CA CA2631646A patent/CA2631646C/en active Active
- 2006-11-29 AT AT06838621T patent/ATE497766T1/de active
- 2006-11-29 ES ES10075728.5T patent/ES2565190T3/es active Active
- 2006-11-29 SI SI200630927T patent/SI1965797T1/sl unknown
- 2006-11-29 WO PCT/US2006/045750 patent/WO2007064738A1/en not_active Ceased
- 2006-11-29 DE DE602006020070T patent/DE602006020070D1/de active Active
-
2011
- 2011-03-21 CY CY20111100306T patent/CY1111355T1/el unknown
-
2012
- 2012-08-28 JP JP2012187515A patent/JP2012229275A/ja not_active Withdrawn
-
2015
- 2015-01-08 JP JP2015002231A patent/JP2015061888A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009518293A5 (https=) | ||
| US11033543B2 (en) | Methods of providing weight loss therapy in patients with major depression | |
| JP7025319B2 (ja) | ナルトレキソン療法における薬物バイオアベイラビリティの増加 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2015518897A (ja) | 過体重および肥満を治療する方法 | |
| JP2005513107A5 (https=) | ||
| JP2013544290A5 (https=) | ||
| TW200524639A (en) | Memantine oral dosage forms | |
| TW201306825A (zh) | 狀況治療之改良套裝 | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| CN102805746B (zh) | 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用 | |
| Bailey et al. | Prevention and management of postoperative pain in oral surgery | |
| CN101015519B (zh) | 一种氯雷他定口服复方药物组合物 | |
| American Dental Association | ADA dental drug handbook: a quick reference | |
| Prenner et al. | Safety of desloratadine syrup in children six months to younger than 2 years of age: a randomized, double-blinded, placebo-controlled study | |
| JP2009539776A (ja) | シクロベンザプリンおよびアセクロフェナクの組み合わせを含んでいる薬学的組成物 | |
| CN106474095A (zh) | 一种用于治疗口腔真菌的口腔粘膜粘贴剂及其制备方法 | |
| JP4318899B2 (ja) | 抗感冒剤 | |
| CN103006657B (zh) | 一种含有愈创木酚的复方化学药物 | |
| ÜSTÜN | PSYCHOTROPIC DRUGS AND THEIR IMPACT ON ORAL HEALTH | |
| Loh et al. | Adrenaline autoinjectors-what pharmacists need to know | |
| Agent | Pr Olopatadine Ophthalmic Solution | |
| Wellbery | Smoking Ban Has Health Benefits for Bar Workers | |
| CN106389544A (zh) | 神志康复组合物 | |
| JP2010159299A (ja) | ロキソプロフェンとケトチフェンを含有する解熱剤組成物 |